Menu
← Oncology Approval Tracker
FDA DECISION ·
Bortezomib for Injection (Hospira)
bortezomib · Hospira
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
An additional bortezomib-for-injection product approved for use in adults with multiple myeloma.
LAMPGEN ANALYSIS
Why it matters
This approval concerns a specific injectable product for an existing myeloma treatment.
What research teams should watch
Use the product-specific reconstitution, route and handling instructions when incorporating it into an order set.
PRIMARY RECORDS